Companies and AI developments

Updates

Daily market commentary, company analyses, investment stories and AI news. Price-only updates require a cumulative move of greater than 15% from the last published assessment. Newest first.

1–20 of 188Times shown in Prague

  1. News from the Singularity The Lean and Mathlib communities certified Levent Alpöge’s formal proof of the Riemann Hypothesis. Other topics: offensive agents targeting MONAI Label, plus Friday context on local Inkling deployment and Oracle financing. Read article →

  2. News from the Singularity Anthropic announced the closing of its IPO and private placement. METR’s new report shows rapidly growing measured capabilities alongside weaker judgment; Google expands agent oversight and explains calling through Gemini. Read article →

  3. Optimistic scenario If UnitedHealth restores pricing discipline, moves OptumHealth toward its 6–8% long-term margin and keeps regulatory costs under control, normalized 2029 earnings could reach roughly USD 30 per share. This is ChatGPT’s conditional optimistic scenario, not a base-case forecast. Read article →

  4. The lower USD 29.51 entry price raises price attractiveness to 4.6/10 under unchanged cases. Conference disclosures add Athena usage, pipeline and Palantir Foundry integration evidence; these are management claims rather than newly reported revenue, so company strength remains 6.9/10.Strength 6.9 → 6.9Attractiveness 3.5 → 4.6Scores changed

  5. The lower USD 2.75 entry price raises price attractiveness to 5.5/10 under unchanged USD 4.32 / 1.28 cases. Company strength remains 6.7/10; risks from Atome and the planned USD 750m AI contribution are unchanged.Strength 6.7 → 6.7Attractiveness 4.9 → 5.5Scores changed

  6. The lower USD 81.31 entry price raises price attractiveness to 6.9/10 at unchanged modeled prices of USD 233.04 / 43.30. Company strength remains 6.6/10; any equity funding at the lower price would dilute shareholders more, and its actual extent remains unverified.Strength 6.6 → 6.6Attractiveness 6.3 → 6.9Scores changed

  7. The lower USD 12.48 entry price raises price attractiveness to 7.6/10 at unchanged three-year prices of USD 35 / 9. Company strength remains 7.2/10; the tokenization coalition and crypto survey do not yet establish incremental earnings.Strength 7.2 → 7.2Attractiveness 7.0 → 7.6Scores changed

  8. At RBC, management clarified Preferred monetization, conversion timing and its cost intentions for 2027; the benefit of new consumer tools remains unquantified. Company strength remains 6.3/10; the lower USD 27.29 entry price improves scenario returns and price attractiveness to 4.0/10.Strength 6.3 → 6.3Attractiveness 3.8 → 4.0Scores changed

  9. The lower entry price of $16.02 improves three-year scenario returns and raises price attractiveness to 4.8/10; company strength remains 5.1/10. The Peptides+ and UK metabolic program launches expand the offering, but adoption, margins and cash contribution have not yet been quantified.Strength 5.1 → 5.1Attractiveness 4.4 → 4.8Scores changed

  10. Daily commentary The Correction Is Confirmed: AI Risk Collides with the Fed, but Bonds Warn of Weaker Growth Read article →

  11. News from the Singularity Anthropic began trading on Nasdaq. Gemini adds Mac computer use and more efficient tool handling, Microsoft brings a small model to Edge, and research agents highlight the importance of checking results. Read article →

  12. The lower USD 330.48 regular close improves the entry price, while the CMS CRUSH proposal intensifies Medicare Advantage audit risk; UNH-specific exposure is unquantified and the proposal is not final. The source therefore raises attractiveness to 6.7/10 with a harsher adverse scenario, while business strength remains 7.2/10.Strength 7.2 → 7.2Attractiveness 5.5 → 6.7Scores changed

  13. The USD 14.41 November 19 regular close is 19.4% below the USD 17.87 price used in the latest completed assessment. The lower entry price raises attractiveness to 6.4/10 with unchanged scenarios; business strength remains 6.1/10 and financing and dilution remain major risks.Strength 6.1 → 6.1Attractiveness 5.2 → 6.4Scores changed

  14. Q3 2026 earnings Q3 documented Connect growth to USD 4.3 billion and a 58% adjusted EBITDA margin, raising business strength to 7.3/10. Separately, the higher USD 26.06 entry price reduces attractiveness to 4.9/10; Kiavi returns and credit quality remain key tests.Strength 7.0 → 7.3Attractiveness 5.2 → 4.9Scores changed

  15. The proxy statement newly quantifies potential dilution at 9.09%, grant burn rate around 6.2% and the SBC margin around 9.5%, clarifying per-share value risk. The lower USD 63.54 price improves returns, but strength of 5.3/10 and attractiveness of 4.0/10 remain unchanged.Strength 5.3 → 5.3Attractiveness 4.0 → 4.0Scores unchanged

  16. Daily commentary Anthropic Succeeds, the Broader Market Does Not: Expensive Money Turns AI Euphoria into Broad-Based Risk Reduction Read article →

  17. News from the Singularity Gemini 4 Neon and GPT-6.2 expand model choice as Google and Microsoft introduce long-running agents. Model ML funding and NVIDIA results show further development across applications and infrastructure. Read article →

  18. New Bally’s filings confirm continuing liquidity risk; the USD 500 million second-lien financing commitment and another USD 60 million from GLPI for Chicago are not yet fully drawn. Strength and attractiveness remain 7.0/10 at USD 38.84: improved completion prospects are offset by increased exposure and continuing substantial doubt about going concern.Strength 7.0 → 7.0Attractiveness 7.0 → 7.0Scores unchanged

  19. TCEQ resumed environmental review of data-center applications, easing one near-term obstacle; an impact on specific STRL contracts is not yet documented. Separately, the lower USD 275.26 entry price raises attractiveness to 7.2/10, while business strength remains 7.8/10.Strength 7.8 → 7.8Attractiveness 6.8 → 7.2Scores changed

  20. Daily commentary Fed Links Further Rate Increases to the Risk of Opaque AI Financing Read article →